Site Search

Displaying results 531 - 540 of 893

'We’ve learned a lot from each other' – an interview with an academic partner in IMI projects

News | 30/08/2017 |

Testimonials

The interaction between the public and private sectors creates interesting synergies and learning opportunities for the academic partners in IMI projects. In an interview with the IMI Programme Office, a veteran of IMI projects, Herman Goossens of the University of Antwerp in ...

"The main value was getting a chance to collaborate" – an interview with an industry partner in SUMMIT

News | 22/08/2017 |

Testimonials

IMI’s SUMMIT project developed new biomarkers, imaging techniques and animal models which will make future preclinical and clinical trials more reliable and efficient, speeding up the development of new drugs for diabetes. In an interview with the IMI programme office, Michael ...

'I would have been a different scientist' – an interview with the U-BIOPRED academic coordinator

News | 22/08/2017 |

Testimonials

U-BIOPRED was one of the first and most successful IMI projects. We asked the project’s scientific coordinator, Peter Sterk of the University of Amsterdam, to share his personal experience of what was it like to participate in this project as an academic partner.

IMI2 – Call 12

Content | 16/08/2017

IMI2 - Call 12 was launched on 19 July 2017 with the following topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data ...

IMI2 – Call 11

Content | 16/08/2017

IMI2 - Call 11 was launched on 19 July 2017 with the following topic: Exploitation of IMI project results More information on the topic can be found in IMI's press release and in the Call Text. Other relevant documents can be found on the IMI2 Call documents page. Projects The ...

IMI Stakeholder Forum

Content | 27/07/2017

Missed the latest Stakeholder Forum which took place in November 2020? See all the presentations and watch video recordings here. The IMI Stakeholder Forum is an annual event which brings together the entire health and medicines research and development (R&D) community. The event ...

70th Edition – July 2017

Newsletter Issue | July 2017

Table of contents:

Regulators, HTAs and payers

Content | 19/07/2017

Interested in applying? Find out about our latest funding opportunities and read our tips for applicants. IMI projects cover the whole medical research and drug development process ranging from understanding the causes of diseases, through drug discovery, all the way to patient ...

Industry

Content | 19/07/2017

'IMI has revolutionised the way companies are working on major R&D programmes.' Carlo Incerti, formerly of Sanofi Genzyme and the IMI Governing Board Read other industry testimonials To mark IMI's 10th anniversary, we created a series of video testimonials from our key partners ...

Associated Partners

Content | 19/07/2017

Under IMI2, any legal entity can become an IMI Associated Partner. This page sets out the benefits of joining us as an Associated Partner, and explains how being an Associated Partner works in practice. Who can become an Associated Partner? The Associated Partner category was ...